Bimekizumab provides rapid and sustained improvements in scalp and nail outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized, double blinded, Phase 2b extension study

Andrew Blauvelt, Kim A Papp, Joseph F Merola, Alice B Gottlieb, Nancy Cross, Cindy Madden, Luke Peterson, Christopher Cioffi, Christopher EM Griffiths
2019 SKIN The Journal of Cutaneous Medicine  
not available.
doi:10.25251/skin.3.supp.34 fatcat:jofvmpx77betnpncbkzc3yh2pm